Search results
Results From The WOW.Com Content Network
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
In late December, Cytokinetics' shares jumped over 82% after aficamten met the main goal of a keenly awaited late-stage study, putting it on track to compete with a rival treatment from Bristol ...
Robert Blum became the CEO of Cytokinetics, Incorporated (NASDAQ:CYTK) in 2007, and we think it's a good time to look...
Shares of the San Francisco-based Cytokinetics surged over 80% to touch a more than a 19-year high of $83.82, on track to add as much as $3.74 bi Cytokinetics heart drug succeeds in closely ...
NASDAQ Biotechnology Index. The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ -listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online .
20. 2008-11-24. 1,384.35. 1,480.41. +6.94%. +6.33%. Largest intraday percentage drops. An intraday percentage drop is defined as the difference between the previous trading session's closing price and the intraday low of the following trading session. The closing percentage change denotes the ultimate percentage change recorded after the ...
Investing in biotechs is not for the faint of heart. Case in point: Cytokinetics (CYTK) shares cratered over 40% following the release of disappointing clinical trial results.Specifically, in the ...
Nasdaq-100. The Nasdaq-100 ( ^NDX [2]) is a stock market index made up of equity securities issued by 100 of the largest non-financial companies listed on the Nasdaq stock exchange. It is a modified capitalization-weighted index. The stocks' weights in the index are based on their market capitalizations, with certain rules capping the influence ...